The dawn of mRNA-based therapeutics for brain diseases

December 27, 2016, Kawasaki Innovation Gateway
mRNA administration into the brain: Intraventricular injection of mRNA encoding luciferase.

The progressive dementia suffered by patients with Alzheimer's disease (AD) affects millions of people globally each year and puts considerable strain on healthcare services. The mechanisms behind AD are not yet clear, and there are no effective therapies available to fully tackle the disease.

Scientists know that one particular protein, amyloid-beta (Aβ), is over-expressed in AD patients and accumulates in plaques in the , disrupting normal functions. In addition, memory loss is thought to be connected with soluble Aβ depositing as insoluble Aβ plaques and infiltrating key parts of the brain. Breaking the connections between these two forms of Aβ may be one way of tackling AD. One protein capable of degrading Aβ is neprilysin (NEP), but this would need to be introduced to the brain via the challenging process of gene introduction.

Now, Keiji Itaka and co-workers at the University of Tokyo have pioneered a safe way of introducing NEP to mouse brains by delivering NEP-carrying mRNA to the brain inside polyplex nanomicelle carriers. Their results may herald the dawn of a new era of targeted therapeutics for AD and other brain diseases.

Nanomicelles are tiny, self-assembling molecular structures that can carry drugs in their core, only dissolving to release their load when they reach target sites in the body. The nanomicelles developed by Itaka's team degrade into non-toxic metabolites after releasing the mRNA into the brain's cells, meaning the procedure is lower risk than other gene delivery methods.

After testing the nanomicelle carriers in cell cultures in the laboratory, the researchers trialled their mRNA carrying system in vivo via an infusion directly into the brains of mice. They found that the nanomicelles successfully introduced NEP mRNA to all target tissues, and found protein levels were boosted across the brain. This resulted in a significant decrease in Aβ concentrations – the first study to demonstrate the therapeutic potential of introducing treatment to the brain via mRNA.

Explore further: Elevating brain protein allays symptoms of Alzheimer's and improves memory

More information: Chin-Yu Lin et al. Messenger RNA-based therapeutics for brain diseases: An animal study for augmenting clearance of beta-amyloid by intracerebral administration of neprilysin mRNA loaded in polyplex nanomicelles, Journal of Controlled Release (2016). DOI: 10.1016/j.jconrel.2016.06.001

Related Stories

Elevating brain protein allays symptoms of Alzheimer's and improves memory

August 25, 2016
Boosting levels of a specific protein in the brain alleviates hallmark features of Alzheimer's disease in a mouse model of the disorder, according to new research published online August 25, 2016 in Scientific Reports.

Treatment approach used in cancer holds promise for Alzheimer's disease

October 21, 2016
Researchers have developed a novel treatment that could block the development of Alzheimer's disease using microscopic droplets of fat to carry drugs into the brain. This treatment approach, which is used to target drugs ...

Protein linked to high risk of Alzheimer's can be removed from brain without hindering learning

October 4, 2016
A protein linked to higher risk of Alzheimer's can be removed from the brains of mice without hindering memory and learning, according to a study that addresses whether potential therapeutics targeting this protein would ...

Innovative method to treat Alzheimer's in mice

April 1, 2013
Researchers from the RIKEN Brain Science Institute report that they successfully used a virus vector to restore the expression of a brain protein and improve cognitive functions, in a mouse model of Alzheimer's disease.

Modified stem cells offer potential pathway to treat Alzheimer's disease

April 15, 2014
UC Irvine neurobiologists have found that genetically modified neural stem cells show positive results when transplanted into the brains of mice with the symptoms and pathology of Alzheimer's disease. The pre-clinical trial ...

3-D imaging reveals unexpected arrangement of plaques in Alzheimer's-afflicted brains

July 14, 2016
Rockefeller University researchers have used a recently-developed imaging technique that makes tissue transparent to visualize brain tissue from deceased patients with Alzheimer's disease, exposing nonrandom, higher-order ...

Recommended for you

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.